Opinion Paper
Artemisinin resistance threat in Central and West Africa needs holistic action
Journal of Public Health in Africa | Vol 17, No 1 | a1405 |
DOI: https://doi.org/10.4102/jphia.v17i1.1405
| © 2026 Loick Pradel Kojom Foko, Amit Sharma
| This work is licensed under CC Attribution 4.0
Submitted: 07 April 2025 | Published: 16 January 2026
Submitted: 07 April 2025 | Published: 16 January 2026
About the author(s)
Loick Pradel Kojom Foko, Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; and, Department of Public Health, Center for Expertise and Research in Applied Biology (CEREBA), Douala, CameroonAmit Sharma, Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India
Abstract
Artemisinin partial resistance (ART-R) has now emerged in the Horn, Eastern and Southern Africa. Mutations in the Plasmodium falciparum kelch13 gene, strongly associated with ART-R, are increasingly reported in several Central and West Africa countries. Here, we opine that the emergence and spread of ART-R in Central and West Africa should not be overlooked given public health, clinical and economic consequences. Again, in addition to the recent funding cuts from the United States (US) government, some regions in these countries are affected by armed conflicts that undoubtedly will disrupt malaria control measures. Thus, measures should be proactively taken to prevent the emergence of ART-R or mitigate its spread in these two regions. We also propose strategies that could be valuable in implementing a near real-time surveillance and information system, will produce high-quality analysis, allow to draw malaria reality-reflecting conclusions, optimally enhance data use and define tailored control and elimination strategies.
Keywords
malaria; drug resistance; Central Africa; West Africa; response
Sustainable Development Goal
Goal 3: Good health and well-being
Metrics
Total abstract views: 433Total article views: 528
